New study released from Memorial Sloan-Kettering Cancer Center
April 1, 2005
New study of 251 patients from Memorial Sloan-Kettering Cancer Center in New York concluded that:
- Stage at presentation was an independent predictor of survival.
- Patients with pathologically negative lymph node involvement have an excellent prognosis
- Suggested that there is no survival benefit to adjuvant chemotherapy.
The authoritative source on Merkel cell carcinoma.
Last updated:
March 24, 2024
About the Disease
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
Testing & Diagnosis
Created in partnership with:
Seattle Multidisciplinary MCC Team, University of Washington MCC Research, and Fred Hutchinson Cancer Center.